171 related articles for article (PubMed ID: 33242852)
1. Polymorphisms in Stress-Related Genes Are Associated with Reduced Cocaine Abuse and Longer Retention in Methadone Maintenance Treatment for Opioid Use Disorder.
Peles E; Levran O; Randesi M; Ott J; Kreek MJ; Adelson M
Eur Addict Res; 2021; 27(3):198-205. PubMed ID: 33242852
[TBL] [Abstract][Full Text] [Related]
2. Genetic Variant in the CRH-binding Protein Gene (CRHBP) is Associated With Cessation of Cocaine Use in Methadone Maintenance Patients With Opioid Addiction.
Peles E; Levran O; Randesi M; Ott J; Kreek MJ; Adelson M
J Addict Med; 2019; 13(6):430-435. PubMed ID: 30844877
[TBL] [Abstract][Full Text] [Related]
3. Gender-specific predictors of methadone treatment outcomes among African Americans at an urban clinic.
Lister JJ; Brown S; Greenwald MK; Ledgerwood DM
Subst Abus; 2019; 40(2):185-193. PubMed ID: 30888262
[No Abstract] [Full Text] [Related]
4. Methadone maintenance therapy and viral suppression among HIV-infected opioid users: The impacts of crack and injection cocaine use.
Socías ME; Wood E; Small W; Dong H; Shoveller J; Kerr T; Montaner J; Milloy MJ
Drug Alcohol Depend; 2016 Nov; 168():211-218. PubMed ID: 27701042
[TBL] [Abstract][Full Text] [Related]
5. Response to methadone maintenance treatment is associated with the MYOCD and GRM6 genes.
Fonseca F; Gratacòs M; Escaramís G; De Cid R; Martín-Santos R; Fernández-Espejo E; Estivill X; Torrens M
Mol Diagn Ther; 2010 Jun; 14(3):171-8. PubMed ID: 20560679
[TBL] [Abstract][Full Text] [Related]
6. Baseline risk factors for drug use among African-American patients during first-month induction/stabilization on methadone.
Lister JJ; Greenwald MK; Ledgerwood DM
J Subst Abuse Treat; 2017 Jul; 78():15-21. PubMed ID: 28554598
[TBL] [Abstract][Full Text] [Related]
7. Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center.
Peles E; Schreiber S; Sason A; Adelson M
Drug Alcohol Depend; 2018 Apr; 185():112-119. PubMed ID: 29432974
[TBL] [Abstract][Full Text] [Related]
8. Gender-specific predictors of retention and opioid abstinence during methadone maintenance treatment.
Levine AR; Lundahl LH; Ledgerwood DM; Lisieski M; Rhodes GL; Greenwald MK
J Subst Abuse Treat; 2015 Jul; 54():37-43. PubMed ID: 25795601
[TBL] [Abstract][Full Text] [Related]
9. Predictors of treatment retention and survival among methadone-maintained patients: A possible role for a functional delta opioid receptor gene variant.
Peles E; Kim Y; Sason A; Adelson M; Levran O
Drug Alcohol Depend; 2023 Sep; 250():110903. PubMed ID: 37531661
[TBL] [Abstract][Full Text] [Related]
10. Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment.
Malik E; Adelson M; Sason A; Schreiber S; Peles E
J Dual Diagn; 2019; 15(4):281-290. PubMed ID: 31530109
[No Abstract] [Full Text] [Related]
11. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and Outcome of Male and Female Methadone Maintenance Patients: MMT in Tel Aviv and Las Vegas.
Adelson M; Linzy S; Peles E
Subst Use Misuse; 2018 Jan; 53(2):230-238. PubMed ID: 28574738
[TBL] [Abstract][Full Text] [Related]
13. Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients.
Ledgerwood DM; Lister JJ; LaLiberte B; Lundahl LH; Greenwald MK
Addict Behav; 2019 Mar; 90():191-195. PubMed ID: 30412910
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of QTc changes among former opiate addicts since admission to methadone maintenance treatment: benzodiazepine risk.
Peles E; Linzy S; Kreek MJ; Adelson M
J Addict Med; 2013; 7(6):428-34. PubMed ID: 24145160
[TBL] [Abstract][Full Text] [Related]
15. Trend differences over 20 years between two methadone maintenance clinics, one with and one without cannabis legalization.
Adelson M; Smith D; Peles E
J Addict Dis; 2021; 39(2):226-233. PubMed ID: 33559536
[TBL] [Abstract][Full Text] [Related]
16. Methadone Maintenance Treatment Discontinuation Among Young People who use Opioids in Vancouver, Canada.
Pilarinos A; Kwa Y; Joe R; Dong H; Grant C; Fast D; Buxton JA; DeBeck K
Can J Psychiatry; 2023 Feb; 68(2):89-100. PubMed ID: 36377240
[TBL] [Abstract][Full Text] [Related]
17. Stress indices in methadone maintenance treatment - Cross sectional and follow up study.
Peles E; Malik E; Altman Y; Baharav A; Schreiber S; Sason A; Adelson M
Psychiatry Res; 2020 Sep; 291():113218. PubMed ID: 32544714
[TBL] [Abstract][Full Text] [Related]
18. The impact of OPRM1's genetic polymorphisms on methadone maintenance treatment in opioid addicts: a systematic review.
Oueslati B; Moula O; Ghachem R
Pharmacogenomics; 2018 Jun; 19(8):741-747. PubMed ID: 29785888
[TBL] [Abstract][Full Text] [Related]
19. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
Peles E; Schreiber S; Adelson M
Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
[TBL] [Abstract][Full Text] [Related]
20. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
